Kevin Laubscher
-
- CAR-T cell therapy research 2
- Colorectal Cancer Treatments and Studies 2
- Cancer Treatment and Pharmacology 2
- Cancer Immunotherapy and Biomarkers 2
-
- Immunotherapy and Immune Responses 2
-
- Chronic Lymphocytic Leukemia Research 2
-
- Amino Acid Enzymes and Metabolism 2
-
- Hepatocellular Carcinoma Treatment and Prognosis 2
- Co-authors
- Mohammed M. DarJeffrey P. HodgeLuke VaughanTerri GelbartDanuta BalickiAnna DeminaErnest BeutlerPaul Garver
- Cited by
- OncologyImmunologyPhysiology
- Partner nations
- United StatesUnited KingdomAustralia
In The Last Decade
Kevin Laubscher
18 papers receiving 424 citations
Peers
Comparison fields: 5 of 68
- Oncology 189
- Immunology 94
- Physiology 109
- Cell Biology 54
- Genetics 26
Countries citing papers authored by Kevin Laubscher
This map shows the geographic impact of Kevin Laubscher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin Laubscher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin Laubscher more than expected).
Fields of papers citing papers by Kevin Laubscher
This network shows the impact of papers produced by Kevin Laubscher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin Laubscher. The network helps show where Kevin Laubscher may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Kevin Laubscher, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 9 | |
| 2 | 2020 | 16 | |
| 3 | 2016 | 18 | |
| 4 | 2015 | 4 | |
| 5 | 2015 | 4 | |
| 6 | 2014 | 1 | |
| 7 | 2013 | 9 | |
| 8 | 2012 | 6 | |
| 9 | 2010 | 16 | |
| 10 | 2010 | 72 | |
| 11 | 2009 | 94 | |
| 12 | 2009 | 63 | |
| 13 | 2006 | 4 | |
| 14 | 1995 | 86 | |
| 15 | 1994 | 24 | |
| 16 | Seemingly diverse activities of beta-alethine. | 1994 | 5 |
| 17 | Vitalethine modulates erythropoiesis and neoplasia. | 1994 | 3 |
| 18 | 1992 | 2 |
About Kevin Laubscher
Kevin Laubscher is a scholar working on Oncology, Genetics and Biochemistry, having authored 18 papers that have together received 436 indexed citations. Recurring topics across this work include Amino Acid Enzymes and Metabolism (2 papers), Chronic Lymphocytic Leukemia Research (2 papers), CAR-T cell therapy research (2 papers), Hepatocellular Carcinoma Treatment and Prognosis (2 papers), Colorectal Cancer Treatments and Studies (2 papers), Cancer Treatment and Pharmacology (2 papers), Cancer Immunotherapy and Biomarkers (2 papers) and Immunotherapy and Immune Responses (2 papers). The work is most often cited by research in Oncology (189 citations), Immunology (94 citations) and Physiology (109 citations). Kevin Laubscher has collaborated with scholars based in United States, United Kingdom and Australia. Frequent co-authors include Mohammed M. Dar, Jeffrey P. Hodge, Luke Vaughan, Terri Gelbart, Danuta Balicki, Anna Demina, Ernest Beutler, Paul Garver, Richard Kefford and Michael Millward. Their work appears in journals such as Journal of Clinical Oncology, Cancer and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.